Antiretroviral Therapy Journal Articles

• U.S. Deaths Among Persons With Diagnosed HIV Infection While deaths attributable to HIV infection are now preventable, this report reveals that HIV remains among the 10 leading causes of death among some demographics.
  Morbidity & Mortality Weekly Report, January 27, 2021
• Diabetes and Depression in Men With or at Risk of HIV Is diabetes associated with a greater risk for depression? How common is this association among men with and without HIV?
  HIV Medicine, January 27, 2021
• Drug Resistance and Virological Failure in InSTI Treatment Might the presence of NRTI transmitted drug resistance translate into a greater risk for virological failure among HIV patients treated with integrase inhibitor-based regimens?
  HIV Medicine, January 20, 2021
• Elevated Serum MMP-2 as a Biomarker for Stable COPD Could MMP-2 serve as a potential biomarker for stable COPD?
  BMC Pulmonary Medicine, January 18, 2021
• Birth Defects and Perinatal Outcomes After INSTI Exposure Might the use of integrase strand inhibitors during pregnancy result in a higher risk for birth defects or other adverse pregnancy outcomes?
  AIDS, January 14, 2021
• ART Outcomes in Late HIV Presenters Treated With INIs or PIs Among patients presenting late for HIV diagnosis, how do treatment outcomes compare between these different ART regimens?
  HIV Medicine, January 13, 2021
• Effectiveness of ART Classes for HIV With High Viral Loads Which ART classes most effectively achieve viral suppression, particularly among patients with high viral loads? How do they compare?
  HIV Medicine, January 06, 2021
• COVID-19 Susceptibility and Outcomes Among People With HIV Are people living with HIV more susceptible to COVID-19 and at a greater risk for severe disease?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, January 06, 2021
• Newly Approved HIV Medications Review the novel antiretroviral drugs and drug combinations which have been recently approved for the treatment of HIV.
  U.S. Pharmacist, December 29, 2020
• Incident T2DM After Initiation of Common HIV ART Drugs How likely are HIV patients to develop prediabetes or type 2 diabetes after ART initiation -- and which drugs are these events associated with?
  AIDS, December 28, 2020
• Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and antiplatelet/anticoagulant treatments in patients at risk of or hospitalized with SARS-CoV-2 infection.
  American Journal of Cardiovascular Drugs, December 23, 2020
• Stopping Prophylaxis in HIV Patients With Talaromycosis A new study examines the question of whether it is safe to discontinue secondary prophylaxis in HIV patients with talaromycosis.
  HIV Medicine, December 11, 2020
• Gender Difference in Mortality of People Living With HIV Findings from a cohort study provide insight into the differences that exist in the all-cause mortality of people living with HIV. How does it vary between men and women?
  HIV Medicine, December 04, 2020
• Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate How do these two antiretroviral regimens for HIV compare in terms of safety and efficacy?
  AIDS, December 04, 2020
• MTX Decreases Tenofovir Exposure in ART-Suppressed HIV A new study finds that methotrexate may alter tenofovir exposure among virally suppressed people living with HIV. Does this warrant a change in dosing during the co-administration of these drugs?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, November 30, 2020
• Post-Exposure Prophylaxis in the Era of PrEP Does post-exposure prophylaxis still have a role in the prevention of HIV after the introduction of pre-exposure prophylaxis?
  HIV Medicine, November 27, 2020
• 2019 Update of the EACS Guidelines for Treatment of HIV This article provides a summary of updates to the 2019 EACS guidelines regarding treatment recommendations for people living with HIV. Find out what's new.
  HIV Medicine, November 20, 2020
• Identifying Regions of Greatest Need for Ending HIV Targeting regions most in need of HIV care improvements could help reduce the number of new infections, with the goal of ending the epidemic in America.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, November 18, 2020
• eGFR Slopes on Tenofovir Alafenamide Did individuals switching to a tenofovir alafenamide-containing ART regimen realize improvement in eGFR slope?
  HIV Medicine, November 13, 2020
• Outcomes of INSTIs, PI/bs and NNRTIs in ART-Naive Persons A new study compares the virological and immunological outcomes among individuals newly initiating ART with these regimens.
  HIV Medicine, November 06, 2020